Biosurveillance Coming to an Airport Near You Re-Posted Nov 13, 2023 By Martin Armstrong 


cdc headquarters

The US Centers for Disease Control and Prevention (CDC) has announced that it will begin screening travelers at airports for COVID and other viruses. Did you think the governments would actually let go of the power they usurped after COVID? The government turned a blind eye to the MILLIONS of illegals entering America from around the world. No one cared about what illnesses they brought with them. The program is intended to target Americans and international travelers who are here legally. Our freedom of movement is at risk for a variety of reasons, and this is merely another step toward the coming restrictions.

CDC Passports

Not only does the government want to restrict our movement, but they also want our biological data. The Traveler-based Genomic Surveillance program collects nasal swab samples from volunteers at six major US international airports. The program began after COVID was released on the population, and they have only expanded their reach. This is not merely a government surveillance program as both Ginkgo Bioworks and XpresSpa Group, which are private and publicly traded organizations, have partnered with the CDC to collect data. The goal? Biosurveillance.

“TGS is a flexible, multimodal platform that consists of three complementary approaches of sample collection from arriving international travelers at U.S. airports, including voluntary nasal swabbing, aircraft wastewater, and airport wastewater sampling to enhance early detection of new SARS-CoV-2 variants and other pathogens, and fills gaps in global surveillance,” the various newsletters states. The government does not care about our drinking water (see: Flint, East Palestine, etc.). They could easily claim contamination and prevent planes from leaving. Also, I don’t know about you, but if I am traveling the last thing I want to do is stop for a medical assessment. This program will only remain voluntary for a limited time.

New York, JFK, San Francisco, Boston, and Washington DC, Dulles will be the first testing zones before this is rolled out to the entire country. “Enhancing surveillance capacity for global mass gathering/migration events,” has been listed as a main goal on the CDC’s website. “Migration events” is an interesting propaganda phrase. We have passports, visas, and other programs in place to track those coming and going. The migration event at the southern border has been of no concern since Biden entered the White House.

In other words, private companies are partnering with the CDC to provide the government with bio data to track everyone who is legally traveling to and from America. They want to keep track of their pawns and will collect our individual bio data to do so. They now have an excuse to prohibit us from traveling or restricting our freedom of movement. Taking it a step further, they believe they can program our DNA like code and control nature, but that is a topic for another time.

CDC Confirms Only 3% of Eligible Americans Have Taken COVID Booster Shot – FDA Confirms May Slightly Increase Strokes in Those Over 85


Posted originally on the CTH on October 25, 2023 | Sundance

Sheesh, talk about the timing of two different articles.  Politico reported yesterday that CDC officials admit only 3% of eligible Americans have chosen to get the latest COVID-19 booster shot, although there could be some delay in reporting.

WASHINGTON – The Biden administration’s campaign to convince Americans to get an annual Covid shot is off to a very slow start.  Even so, the nation’s top disease-fighting official says the U.S. remains “on track” to hit last year’s uptake levels, which crested at just 17 percent of the U.S. population. (more)

Today, the FDA announces when COVID booster is combined with Flu shot, there is a slight elevated risk of blood clots causing stroke in people over the age 85.

CNN –  Vaccines for Covid-19 and influenza may slightly increase the risk of strokes caused by blood clots in the brains of seniors, particularly when the two vaccines are given at the same time and when they are given to adults who are age 85 and older, according to a new study.

The safety signal was detected by experts at the US Food and Drug Administration who analyzed data from Medicare claims.

It is the second study to find an elevated risk of stroke for seniors after Covid-19 and flu vaccinations given together. The US Centers for Disease Control and FDA issued a public communication in January explaining that one of their near real-time vaccine safety monitoring studies—called the Vaccine Safety Datalink–had picked up a small and uncertain risk of stroke for older adults who received a dose of Pfizer’s bivalent Covid-19 vaccine and a high-dose or adjuvanted flu shot on the same day. That study triggered the FDA’s broader look at strokes after vaccination noted in the medical records of seniors on Medicare. (read more)

Meanwhile, trust in U.S. government institutions is at an all-time low.

PEW RESEARCH – Public trust in the federal government, which has been low for decades, has returned to near record lows following a modest uptick in 2020 and 2021. Currently, fewer than two-in-ten Americans say they trust the government in Washington to do what is right “just about always” (1%) or “most of the time” (15%). This is among the lowest trust measures in nearly seven decades of polling. Last year, 20% said they trusted the government just about always or most of the time. (read more)

Gee, ya think?

None of this is related folks….  It’s all just disconnected. Swear!

Meanwhile, Suspicious Cat remains, well,… increasingly suspicious.

FDA Approves COVID Election Booster to Begin Immediately


Posted originally on the CTH on September 11, 2023 | Sundance 

As expected, the FDA has approved a new series of COVID-19 “booster” vaccines which are immediately available for anyone who trusts the institutions of government to be focused on your health and wellbeing.   For everyone else, hard pass.

“The FDA is confident in the safety and effectiveness of these updated vaccines and the agency’s benefit-risk assessment demonstrates that the benefits of these vaccines for individuals 6 months of age and older outweigh their risks.”

FDA – Today, the U.S. Food and Drug Administration took action approving and authorizing for emergency use updated COVID-19 vaccines formulated to more closely target currently circulating variants and to provide better protection against serious consequences of COVID-19, including hospitalization and death. Today’s actions relate to updated mRNA vaccines for 2023-2024 manufactured by ModernaTX Inc. and Pfizer Inc. Consistent with the totality of the evidence and input from the FDA’s expert advisors, these vaccines have been updated to include a monovalent (single) component that corresponds to the Omicron variant XBB.1.5.

What You Need to Know

• Individuals 5 years of age and older regardless of previous vaccination are eligible to receive a single dose of an updated mRNA COVID-19 vaccine at least 2 months since the last dose of any COVID-19 vaccine.

• Individuals 6 months through 4 years of age who have previously been vaccinated against COVID-19 are eligible to receive one or two doses of an updated mRNA COVID-19 vaccine (timing and number of doses to administer depends on the previous COVID-19 vaccine received).

• Unvaccinated individuals 6 months through 4 years of age are eligible to receive three doses of the updated authorized Pfizer-BioNTech COVID-19 Vaccine or two doses of the updated authorized Moderna COVID-19 Vaccine.

• The FDA is confident in the safety and effectiveness of these updated vaccines and the agency’s benefit-risk assessment demonstrates that the benefits of these vaccines for individuals 6 months of age and older outweigh their risks.

• Individuals who receive an updated mRNA COVID-19 vaccine may experience similar side effects as those reported by individuals who previously received mRNA COVID-19 vaccines as described in the respective prescribing information or fact sheets.

• The updated vaccines are expected to provide good protection against COVID-19 from the currently circulating variants. Barring the emergence of a markedly more virulent variant, the FDA anticipates that the composition of COVID-19 vaccines may need to be updated annually, as is done for the seasonal influenza vaccine.

• The U.S. Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices will meet tomorrow (Sept. 12), to discuss clinical recommendations on who should receive an updated vaccine, as well as further considerations for specific populations such as immunocompromised and older individuals.

• Manufacturers have publicly announced that the updated vaccines would be ready this fall, and the FDA anticipates that the updated vaccines will be available in the near future. (read more)